쮸떴눈첵

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Celltrion

In the last 7 days

PR Newswire (Press Release)17:35 31-Oct-24

Korea Biomedical Review15:37 31-Oct-24

PR Newswire (Press Release)06:25 30-Oct-24

The Korea Herald16:38 29-Oct-24

Korea Biomedical Review16:05 28-Oct-24

In the last month

Korea Biomedical Review17:17 25-Oct-24

Scrip Pharma Intelligence23:16 24-Oct-24

Scrip Pharma Intelligence00:01 24-Oct-24

Korea JoongAng Daily20:52 22-Oct-24

Scrip Pharma Intelligence17:56 22-Oct-24

Korea Biomedical Review17:05 21-Oct-24

Korea JoongAng Daily20:30 18-Oct-24

Korea Biomedical Review15:09 18-Oct-24

Scrip Pharma Intelligence03:58 16-Oct-24

PharmaTimes22:25 15-Oct-24

Business Wire (Press Release)17:40 15-Oct-24

Korea Biomedical Review13:44 10-Oct-24

JD Supra03:22 10-Oct-24

JD Supra05:56 9-Oct-24

JD Supra08:01 8-Oct-24

view more headlines

31 Oct 17:35

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.